SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Constellium SE (CSTM) trades at a trailing P/E of 16.8, forward P/E of 15.1. Trailing earnings yield is 5.94%, forward earnings yield 6.62%. PEG 0.04 (Peter Lynch undervalued ≤1.0). Graham Number is $16.55.
Criteria proven by this page:
- VALUE (74/100, Pass) — P/E is below market average (16.8); PEG ≤ 1.0 — Peter Lynch undervalued (0.04); earnings yield beats bond yields (5.94%).
- Forward P/E 15.1 (down from trailing 16.8) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 5.94% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 6.62% as earnings recover.
- Analyst consensus target $27.67 (-9.4% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 60/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
74/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CSTM
Valuation Multiples
P/E (TTM)16.8
Forward P/E15.1
PEG Ratio0.04
Forward PEG2.56
P/B Ratio4.33
P/S Ratio0.55
EV/EBITDA8.2
Per Share Data
EPS (TTM)$1.75
Forward EPS (Est.)$2.02
Book Value / Share$6.95
Revenue / Share$52.66
FCF / Share$1.17
Yields & Fair Value
Earnings Yield5.94%
Forward Earnings Yield6.62%
Dividend Yield0.00%
Graham Number$16.55
SharesGrow IV$15.53 (-49.1%)
Analyst Target$27.67 (-9.4%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
-147.8 |
1.49 |
-1.02 |
0.12 |
- |
| 2017 |
-33.9 |
-0.05 |
-3.21 |
0.20 |
- |
| 2018 |
4.4 |
-0.01 |
-6.73 |
0.14 |
- |
| 2019 |
24.8 |
-0.36 |
-15.18 |
0.25 |
- |
| 2020 |
-75.6 |
0.56 |
-11.29 |
0.33 |
- |
| 2021 |
8.6 |
-0.01 |
7.13 |
0.36 |
- |
| 2022 |
5.2 |
0.35 |
2.03 |
0.19 |
- |
| 2023 |
21.5 |
-0.36 |
3.19 |
0.37 |
- |
| 2024 |
25.8 |
-0.46 |
2.04 |
0.20 |
- |
| 2025 |
9.6 |
0.02 |
2.77 |
0.31 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.04 |
$4.74B |
$-4M |
-0.1% |
| 2017 |
$-0.28 |
$5.24B |
$-31M |
-0.6% |
| 2018 |
$1.36 |
$5.69B |
$188M |
3.3% |
| 2019 |
$0.41 |
$5.91B |
$59M |
1% |
| 2020 |
$-0.12 |
$4.88B |
$-17M |
-0.3% |
| 2021 |
$1.82 |
$6.15B |
$257M |
4.2% |
| 2022 |
$2.02 |
$8.12B |
$301M |
3.7% |
| 2023 |
$0.84 |
$7.24B |
$125M |
1.7% |
| 2024 |
$0.37 |
$7.08B |
$54.06M |
0.8% |
| 2025 |
$1.91 |
$8.45B |
$272.92M |
3.2% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$2.01 |
$1.96 – $2.06 |
$9.59B |
$9.32B – $9.86B |
2 |
| 2027 |
$2.34 |
$2.17 – $2.50 |
$9.67B |
$9.34B – $10B |
2 |
| 2028 |
$0.00 |
$0.00 – $0.00 |
$9.85B |
$9.58B – $10.13B |
1 |
| 2029 |
$0.00 |
$0.00 – $0.00 |
$10.95B |
$10.65B – $11.26B |
0 |
| 2030 |
$0.00 |
$0.00 – $0.00 |
$11.71B |
$11.38B – $12.03B |
0 |
